Guillain-Barré syndrome after exogenous gangliosides in Italy

Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome afte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 1993-12, Vol.307 (6917), p.1463-1464
Hauptverfasser:	Landi, G, D'Alessandro, R, Dossi, B C, Ricci, S, Simone, I L, Ciccone, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antibodies Biological and medical sciences Drug therapy Drug toxicity and drugs side effects treatment Female Gangliosides Gangliosides - adverse effects Humans Italy - epidemiology Low back pain Male Medical research Medical sciences Middle Aged Neurological disorders Neurology Pharmacology. Drug treatments Polyneuropathies Polyradiculoneuropathy - chemically induced Polyradiculoneuropathy - epidemiology Risk Factors Strokes Toxicity: nervous system and muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome after taking them.
ISSN:	0959-8138 0959-8146 1468-5833 1756-1833
DOI:	10.1136/bmj.307.6917.1463